Sutro Biopharma
STRO
#9292
Rank
A$0.21 B
Marketcap
A$12.99
Share price
-1.38%
Change (1 day)
898.95%
Change (1 year)

Earnings for Sutro Biopharma (STRO)

Earnings in 2026 (TTM): -A$0.21 Billion

According to Sutro Biopharma's latest financial reports the company's current earnings are A$45.7 Million. In 2025 the company made an earning of -A$0.23 Billion, an increase over its 2024 earnings that were of -A$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sutro Biopharma from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.21 Billion-8.55%
2025 -A$0.23 Billion-21.54%
2024 -A$0.29 Billion193.07%
2023 -A$97.98 Million-42.79%
2022 -A$0.18 Billion10.7%
2021 -A$0.16 Billion265.05%
2020 -A$42.38 Million-45.42%
2019 -A$77.65 Million48.65%
2018 -A$52.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.25 Billion 14.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$27.44 Million-86.95%๐Ÿ‡บ๐Ÿ‡ธ USA